DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Equity Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Transactions / J••••••• T••••• S•••••
O•••• S••••••• Announces Definitive Agreement to Acquire the JTS Extendible Prosthesis
Add-on acquisitionannouncedadd-onannounced Jun 13, 2022Fact
What happened
- Target
- J••••••• T••••• S•••••
- Platform
- O•••• S•••••••add-on basis: O•••• S•••••••, Inc., a rapidly growing, leading innovator of solutions for musculoskeletal oncology and complex orthopaedic conditions, announced today that it has entered into a definitive agreement with Stryker to acquire the J••••••• T••••• S••••• ( JTS ). | O•••• S•••••••, Inc. is held by 1••• C•••••• on its portfolio page; published on 1••• C••••••'s own news page
- Control
- Control
- Share acquired
- unknown
- Industry
- unknown
- Target location
- unknown
- Seller kind
- unknown
- Rollover
- unknown
Values, only where disclosed
- Enterprise value
- Not disclosed
- Purchase price
- Not disclosed
- Equity value
- Not disclosed
- Target revenue
- Not disclosed
- Target EBITDA
- Not disclosed
- Multiple
- Not disclosed
Parties and roles
3 named
Buy side
- “••• Locked”
- “••• Locked”
Side not stated
- “••• Locked”
Evidence
“••• Locked”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 15, 2026